The active ingredient of the drug determines the effect of the drug, and the compatibility affects the content of the active ingredient of the drug, which in turn affects the exertion of the efficacy. This study partly clarifies the rationality and compatibility of AM‐PR in the treatment of FC.
Xiaoting Wang+4 more
wiley +1 more source
Corrigendum: Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. [PDF]
Hurler L+12 more
europepmc +1 more source
The flowchart of this research. Abstract Background Dry eye disease (DED) predominantly results from elevated tear film osmolarity, which can not only cause ocular inconvenience but may lead to visual impairments, severely compromising patient well‐being and exerting substantial economic burdens as well.
Ziyu Liu+9 more
wiley +1 more source
Objectives Rapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative methods are essential for accurately understanding the
Gianmarco Abbadessa+11 more
wiley +1 more source
Correlation between serum complement component 4 levels and tubular atrophy in patients with lupus nephritis. [PDF]
Chang Z, Hu H, Cheng Y, Xu R, Wan Q.
europepmc +1 more source
This final part 3 review builds on the practical applications discussed in part 2 and explores how artificial intelligence (AI) is transforming data management, neurological education, and neurological care across large healthcare networks and datasets. The review also highlights AI's role in real‐world and synthetic data, digital twins, and innovative
Matthew Rizzo
wiley +1 more source
Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance. [PDF]
Gaffar NR+2 more
europepmc +1 more source
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain-Barré Syndrome. [PDF]
Mohammad QD+11 more
europepmc +1 more source
Drug-resistant epilepsy associated with peripheral complement decreases and sex-specific cytokine imbalances: a pilot study. [PDF]
Pinzon-Hoyos N+5 more
europepmc +1 more source
Two New Kindreds with Complete Factor D Deficiency. [PDF]
Puel M+10 more
europepmc +1 more source